☰

Vlad Popovici - Publications

Affiliations: 
Bioinformatics Core Facility Swiss Institute of Bioinformatics 
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Stenvang J, Budinská E, Cutsem EVV, Bosman F, Popovici V, Brünner N. An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers. 12: 977. PMID 32326511 DOI: 10.3390/Cancers12040977  0.355
2019 Eduardo MB, Popovici V, Imboden S, Aebi S, Ballabio N, Altermatt HJ, Günthert A, Jaggi R. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases. Bmc Cancer. 19: 549. PMID 31174485 DOI: 10.1186/S12885-019-5752-8  0.341
2019 Pačínková A, Popovici V. Cross-platform Data Analysis Reveals a Generic Gene Expression Signature for Microsatellite Instability in Colorectal Cancer. Biomed Research International. 2019: 6763596-6763596. PMID 31008109 DOI: 10.1155/2019/6763596  0.398
2018 Forsythe N, Refaat A, Javadi A, Khawaja H, Weir JA, Emam H, Allen WL, Burkamp F, Popovici V, Jithesh PV, Isella C, LaBonte MJ, Mills IG, Johnston PG, Van Schaeybroeck S. The unfolded protein response: a novel therapeutic target for poor prognostic BRAF mutant colorectal cancer. Molecular Cancer Therapeutics. PMID 29483217 DOI: 10.1158/1535-7163.Mct-17-0603  0.314
2018 Ihnatova I, Popovici V, Budinska E. A critical comparison of topology-based pathway analysis methods. Plos One. 13. PMID 29370226 DOI: 10.1371/Journal.Pone.0191154  0.362
2017 Popovici V, Křenek A, Budinská E. Identification of "BRAF-Positive" Cases Based on Whole-Slide Image Analysis Biomed Research International. 2017: 3926498. PMID 28523274 DOI: 10.1155/2017/3926498  0.365
2017 Popovici V, Budinská E, Dušek L, Kozubek M, Bosman F. Image-based surrogate biomarkers for molecular subtypes of colorectal cancer Bioinformatics. 33: 2002-2009. PMID 28158480 DOI: 10.1093/Bioinformatics/Btx027  0.408
2016 Popovici V, Budinská E, Čápková L, Schwarz D, Dušek L, Feit J, Jaggi R. Joint analysis of histopathology image features and gene expression in breast cancer Bmc Bioinformatics. 17: 209-209. PMID 27170365 DOI: 10.1186/S12859-016-1072-Z  0.33
2016 Maxwell P, Favero JD, Fuchs M, Tabernero J, Maughan T, Middleton M, Addams R, Rolfo C, Hennessey B, Laurent-Puig P, Bardelli A, Andre T, Popovici V, Johnstone P, Wilson R, et al. Abstract 1396: Validation of a MEK/MET-specific NGS panel for early phase trial interrogation Cancer Research. 76: 1396-1396. DOI: 10.1158/1538-7445.Am2016-1396  0.377
2014 Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD, Klingbiel D, Bosman FT, Delorenzi M, Tejpar S. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 1995-2001. PMID 25057166 DOI: 10.1093/Annonc/Mdu275  0.336
2013 Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. Bmc Cancer. 13: 439. PMID 24073892 DOI: 10.1186/1471-2407-13-439  0.314
2013 Budinska E, Popovici V, Tejpar S, D'Ario G, Lapique N, Sikora KO, Di Narzo AF, Yan P, Hodgson JG, Weinrich S, Bosman F, Roth A, Delorenzi M. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. The Journal of Pathology. 231: 63-76. PMID 23836465 DOI: 10.1002/Path.4212  0.443
2013 Budinska E, Janotova A, Tejpar S, Popovici V, D'Ario G, Lapique N, Sikora KO, Narzo AFD, Yan P, Hodgson JG, Weinrich S, Bosman F, Roth A, Delorenzi M. Abstract 823: Colorectal cancer heterogeneity from a gene expression perspective. Cancer Research. 73: 823-823. DOI: 10.1158/1538-7445.Am2013-823  0.425
2013 Vecchione L, Gambino V, D'Ario G, Sun T, Simon I, Popovici V, Delorenzi M, Bernards R, Tejpar S. Abstract 1219: Identification of synthetic lethal interactions with the BRAF oncogene in colorectal cancer. Cancer Research. 73: 1219-1219. DOI: 10.1158/1538-7445.Am2013-1219  0.395
2013 Vinolo E, Marangoni E, Serra V, Amant F, Bertotti A, Biankin AV, Børresen-Dale A, Bruna A, Budinská E, Byrne A, Caldas C, Chang D, Clarke R, Hermans E, Hidalgo M, ... ... Popovici V, et al. Abstract A8: The EurOPDX consortium: Sharing patient tumor-derived xenografts for collaborative multicentric preclinical trials. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-A8  0.352
2012 Tian S, Roepman P, Popovici V, Michaut M, Majewski I, Salazar R, Santos C, Rosenberg R, Nitsche U, Mesker WE, Bruin S, Tejpar S, Delorenzi M, Bernards R, Simon I. A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency. The Journal of Pathology. 228: 586-95. PMID 22926706 DOI: 10.1002/Path.4092  0.401
2012 Xie T, D' Ario G, Lamb JR, Martin E, Wang K, Tejpar S, Delorenzi M, Bosman FT, Roth AD, Yan P, Bougel S, Di Narzo AF, Popovici V, Budinská E, Mao M, et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. Plos One. 7: e42001. PMID 22860045 DOI: 10.1371/Journal.Pone.0042001  0.323
2012 Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, Hodgson G, Van Cutsem E, Xie T, Bosman FT, Roth AD, Delorenzi M. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1288-95. PMID 22393095 DOI: 10.1200/Jco.2011.39.5814  0.384
2011 Popovici V, Budinska E, Tejpar S, Roth A, Bosman F, Weinrich S, Hodgson G, Delorenzi M. Abstract 4722: A BRAF-mutated gene expression signature identifies BRAF wild type colon cancer patients with poor prognosis Cancer Research. 71: 4722-4722. DOI: 10.1158/1538-7445.Am2011-4722  0.432
2010 Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, Goodsaid FM, Pusztai L, Shaughnessy JD, Oberthuer A, Thomas RS, Paules RS, Fielden M, ... ... Popovici V, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nature Biotechnology. 28: 827-38. PMID 20676074 DOI: 10.1038/Nbt.1665  0.354
2010 Popovici V, Chen W, Gallas BG, Hatzis C, Shi W, Samuelson FW, Nikolsky Y, Tsyganova M, Ishkin A, Nikolskaya T, Hess KR, Valero V, Booser D, Delorenzi M, Hortobagyi GN, et al. Effect of training-sample size and classification difficulty on the accuracy of genomic predictors. Breast Cancer Research : Bcr. 12: R5. PMID 20064235 DOI: 10.1186/Bcr2468  0.307
2010 Delorenzi M, Budinska E, Popovici V, Estrella H, Pavlicek A, Yan P, Weinrich S, Bosman F, Tejpar S, Roth A. Molecular classes in CRC: Characterization of MSI by expression profiling in the translational study of the PETACC 3-EORTC 40993- SAKK 60-00 trial. Journal of Clinical Oncology. 28: 3597-3597. DOI: 10.1200/Jco.2010.28.15_Suppl.3597  0.349
2010 Tejpar S, Popovici V, Delorenzi M, Budinska E, Estrella H, Mao M, Yan P, Weinrich S, Cutsem EV, Roth A. Mutant KRAS and BRAF gene expression profiles in colorectal cancer: Results of the translational study on the PETACC 3-EORTC 40993-SAKK 60-00 trial. Journal of Clinical Oncology. 28: 3505-3505. DOI: 10.1200/Jco.2010.28.15_Suppl.3505  0.404
2009 Popovici V, Goldstein DR, Antonov J, Jaggi R, Delorenzi M, Wirapati P. Selecting control genes for RT-QPCR using public microarray data. Bmc Bioinformatics. 10: 42. PMID 19187545 DOI: 10.1186/1471-2105-10-42  0.379
2009 Aebi S, Antonov J, Popovici V, Delorenzi M, Giobbie-Hurder A, Viale G, Thürlimann B, Altermatt H, Jaggi R. Risk assessment of relapse in Swiss participants of BIG 1-98 with grade 2 early breast cancer by gene expression profiling using RNA from formalin-fixed, paraffin embedded (FFPE) tissue. Cancer Research. 69: 1073. DOI: 10.1158/0008-5472.Sabcs-1073  0.331
2008 Oberli A, Popovici V, Delorenzi M, Baltzer A, Antonov J, Matthey S, Aebi S, Altermatt HJ, Jaggi R. Expression profiling with RNA from formalin-fixed, paraffin-embedded material. Bmc Medical Genomics. 1: 9. PMID 18423048 DOI: 10.1186/1755-8794-1-9  0.34
Show low-probability matches.